NO20063875L - Forbindelser som anvendes for behandling av sykdommer - Google Patents

Forbindelser som anvendes for behandling av sykdommer

Info

Publication number
NO20063875L
NO20063875L NO20063875A NO20063875A NO20063875L NO 20063875 L NO20063875 L NO 20063875L NO 20063875 A NO20063875 A NO 20063875A NO 20063875 A NO20063875 A NO 20063875A NO 20063875 L NO20063875 L NO 20063875L
Authority
NO
Norway
Prior art keywords
diseases
treatment
compounds used
compounds
disorders
Prior art date
Application number
NO20063875A
Other languages
English (en)
Norwegian (no)
Inventor
Kim James
Mark Edward Bunnage
Alan Daniel Brown
Paul Alan Glossop
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04290725A external-priority patent/EP1577291A1/en
Priority claimed from GB0425064A external-priority patent/GB0425064D0/en
Priority claimed from PCT/IB2005/000640 external-priority patent/WO2005090287A2/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO20063875L publication Critical patent/NO20063875L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20063875A 2004-03-17 2006-08-30 Forbindelser som anvendes for behandling av sykdommer NO20063875L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290725A EP1577291A1 (en) 2004-03-17 2004-03-17 Phenylethanolamine derivatives as beta-2 agonists
US59179004P 2004-07-27 2004-07-27
GB0425064A GB0425064D0 (en) 2004-11-12 2004-11-12 Compounds useful for the treatment of diseases
PCT/IB2005/000640 WO2005090287A2 (en) 2004-03-17 2005-03-10 Phenylethanolamine derivatives as beta-2 agonists

Publications (1)

Publication Number Publication Date
NO20063875L true NO20063875L (no) 2006-09-26

Family

ID=34961252

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063875A NO20063875L (no) 2004-03-17 2006-08-30 Forbindelser som anvendes for behandling av sykdommer

Country Status (13)

Country Link
KR (1) KR20070026420A (es)
AP (1) AP2006003743A0 (es)
AR (1) AR048267A1 (es)
EC (1) ECSP066854A (es)
IL (1) IL177754A0 (es)
MA (1) MA28475B1 (es)
NL (1) NL1028559C2 (es)
NO (1) NO20063875L (es)
PA (1) PA8626401A1 (es)
PE (1) PE20060123A1 (es)
SV (1) SV2005002052A (es)
TW (1) TWI281396B (es)
UY (1) UY28810A1 (es)

Also Published As

Publication number Publication date
IL177754A0 (en) 2006-12-31
MA28475B1 (fr) 2007-03-01
ECSP066854A (es) 2006-11-24
PE20060123A1 (es) 2006-03-08
SV2005002052A (es) 2005-12-13
AP2006003743A0 (en) 2006-10-31
TWI281396B (en) 2007-05-21
TW200534846A (en) 2005-11-01
PA8626401A1 (es) 2006-05-16
NL1028559A1 (nl) 2005-09-20
KR20070026420A (ko) 2007-03-08
UY28810A1 (es) 2005-10-31
NL1028559C2 (nl) 2006-04-19
AR048267A1 (es) 2006-04-12

Similar Documents

Publication Publication Date Title
NO20062983L (no) Sulfonamid-derivater for behandling av sykdommer
NO20063761L (no) Sulfonamidderivater for behandling av sykdommer
NO20084005L (no) Aminderivater
NO20064577L (no) Tetrahydronaftyndin-derivater nyttige som histamin H3 reseptorligander
EA200601462A1 (ru) Соединения для лечения заболеваний
NO20055854L (no) (2-hyroksy-2-(4-hydroksy-3-hydroksymetylfenyl)--etylamino)-propylfenylderivater som beta2 agonister
NO20050828L (no) lndol-3-svovelderivater
TW200505862A (en) 2-amino-pyridine derivatives useful for the treatment of diseases
WO2004080964A8 (en) Indole derivatives useful for the treatment of diseases
RS70104A (en) Nicotinamide derivatives useful as pde4 inhibitors
IL196543A (en) Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20074592L (no) Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
SE0301010D0 (sv) Novel compounds
NO20045281L (no) Tiazolidinoner og anvendelse derav som polo-lignende kinaseinhibitorer
TW200607494A (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
NO20082496L (no) Pyrazinderivater
NO20090910L (no) Sulfonamid-derivater som adrenerge agonister og muskariniske antagonister
NO20074258L (no) Pyridin-2-karboksamidderivater som MGLUR5 antagonister
SE0301009D0 (sv) Novel compounds
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
NO20051503L (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
NO20073631L (no) Metasubstituerte tiazolidinoner, fremgangsmate for fremstilling og anvendelse av disse som legemiddel
EA200601510A1 (ru) Производные фенилэтаноламина в качестве бета-2-агонистов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application